{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:09:43Z","timestamp":1781604583444,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,4]]},"DOI":"10.7759\/cureus.20945","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T06:38:42Z","timestamp":1641364722000},"source":"Crossref","is-referenced-by-count":3,"title":["There\u2019s Danger in the Drops: Systemic Effects of Ophthalmic Drops Used to Treat Glaucoma"],"prefix":"10.7759","author":[{"given":"Claire","family":"Haga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhimanyu S","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Farford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Glaucoma","author":"Dietze J","year":"2021","unstructured":"Dietze J, Blair K, Havens SJ. Glaucoma. StatPearls, Treasure Island, FL; 2021."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2021.01.004","article-title":"Glaucoma","volume":"105","author":"Kang JM","year":"2021","unstructured":"Kang JM, Tanna AP. Glaucoma. Med Clin North Am. 2021, 105:493-510. 10.1016\/j.mcna.2021.01.004","journal-title":"Med Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2015.05.008","article-title":"Glaucoma","volume":"42","author":"Mantravadi AV","year":"2015","unstructured":"Mantravadi AV, Vadhar N. Glaucoma. Prim Care. 2015, 42:437-49. 10.1016\/j.pop.2015.05.008","journal-title":"Prim Care"},{"key":"ref4","article-title":"Glaucoma","volume":"93","author":"Gupta D","year":"2016","unstructured":"Gupta D, Chen PP. Glaucoma. Am Fam Physician. 2016, 93:668-74.","journal-title":"Am Fam Physician"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.09.003","article-title":"Long-term trends in glaucoma-related blindness in Olmsted County, Minnesota","volume":"121","author":"Malihi M","year":"2014","unstructured":"Malihi M, Moura Filho ER, Hodge DO, Sit AJ. Long-term trends in glaucoma-related blindness in Olmsted County, Minnesota. Ophthalmology. 2014, 121:134-41. 10.1016\/j.ophtha.2013.09.003","journal-title":"Ophthalmology"},{"key":"ref6","article-title":"Chronic open-angle glaucoma. Review for primary care physicians","volume":"51","author":"Adatia FA","year":"2005","unstructured":"Adatia FA, Damji KF. Chronic open-angle glaucoma. Review for primary care physicians. Can Fam Physician. 2005, 51:1229-37.","journal-title":"Can Fam Physician"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/opth.s6501","article-title":"Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis","volume":"3","author":"Eyawo O","year":"2009","unstructured":"Eyawo O, Nachega J, Lefebvre P, et al.. Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis. Clin Ophthalmol. 2009, 3:447-56. 10.2147\/opth.s6501","journal-title":"Clin Ophthalmol"},{"key":"ref8","article-title":"Topical therapies for glaucoma: what family physicians need to know","volume":"59","author":"Lewis PR","year":"1999","unstructured":"Lewis PR, Phillips TG, Sassani JW. Topical therapies for glaucoma: what family physicians need to know. Am Fam Physician. 1999, 59:1871-9.","journal-title":"Am Fam Physician"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.1996.tb00720.x","article-title":"The effects of nasolacrimal canal blockage on topical medications for glaucoma","volume":"74","author":"Arit\u00fcrk N","year":"1996","unstructured":"Arit\u00fcrk N, Oge I, Erkan D, S\u00fcll\u00fc Y, Sahin M. The effects of nasolacrimal canal blockage on topical medications for glaucoma. Acta Ophthalmol Scand. 1996, 74:411-3. 10.1111\/j.1600-0420.1996.tb00720.x","journal-title":"Acta Ophthalmol Scand"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1444-0938.2010.00587.x","article-title":"Silicone punctal plugs as an adjunctive therapy for open-angle glaucoma and ocular hypertension","volume":"94","author":"Opitz DL","year":"2011","unstructured":"Opitz DL, Tung S, Jang US, Park JJ. Silicone punctal plugs as an adjunctive therapy for open-angle glaucoma and ocular hypertension. Clin Exp Optom. 2011, 94:438-42. 10.1111\/j.1444-0938.2010.00587.x","journal-title":"Clin Exp Optom"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(89)90214-6","article-title":"Punctal occlusion and topical medications for glaucoma","volume":"107","author":"Huang TC","year":"1989","unstructured":"Huang TC, Lee DA. Punctal occlusion and topical medications for glaucoma. Am J Ophthalmol. 1989, 107:151-5. 10.1016\/0002-9394(89)90214-6","journal-title":"Am J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S118409","article-title":"Systemic side effects of eye drops: a pharmacokinetic perspective","volume":"10","author":"Farkouh A","year":"2016","unstructured":"Farkouh A, Frigo P, Czejka M. Systemic side effects of eye drops: a pharmacokinetic perspective. Clin Ophthalmol. 2016, 10:2433-41. 10.2147\/OPTH.S118409","journal-title":"Clin Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/75278-theres-danger-in-the-drops-systemic-effects-of-ophthalmic-drops-used-to-treat-glaucoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:28Z","timestamp":1707507328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/75278-theres-danger-in-the-drops-systemic-effects-of-ophthalmic-drops-used-to-treat-glaucoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.20945","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,4]]}}}